menu ☰
menu ˟

Baricitinib superior to methotrexate in treatment of patients with RA

29 Sep 2015
Eli Lilly and Company and Incyte Corporation announced positive results from a phase 3 trial evaluating baricitinib against methotrexate to treat patients with rheumatoid arthritis, according to a company press release. A cohort of 600 patients with ...

Click here to view the full article which appeared in Rheumatology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.